Introducing our NEW Oncology Market Access Insights Report

MORSE Consulting Inc. is excited to announce the release of our comprehensive Oncology Market Access Insights Report for 2024. This in-depth report provides a detailed analysis of reimbursement, pricing, and market access trends specific to oncology drugs in Canada.

Our team of experts has leveraged MORSE’s extensive HTA and public payer expertise to deliver invaluable insights that will help pharmaceutical companies navigate the complex oncology market access landscape. The report includes:

  • HTA Insights and Trends for Oncology Treatments
    •  Analyses of Project Orbis drugs
    •  Insights on novel endpoints
  • Implications of Companion Diagnostics
  • Oncology Negotiations Trends
    • Factors influencing pCPA mandates
    • Factors that affect negotiations & timelines
    • Targeted Negotiation Process (TNP) Trends
    • Insights into increasing oncology negotiations closed without LOI
  • Pricing Landscape & General Mandates for Oncology Negotiations
    • Metrics to help determine net price potential in key oncology therapeutic areas
  • Innovative Agreements
  • Multi-Indication Negotiations
    • Preparing for multi-indication launches and negotiations
    • Case studies on how to facilitate future indication access timelines
  • Implications of Combination Therapies on Access Timelines and Negotiations
  • pCPA Temporary Access Process (pTAP) Outlook
  • Best Practices for Stakeholder Engagement

This comprehensive report is an essential tool for pharmaceutical companies looking to optimize their market access strategies for oncology products in Canada. With our data-driven insights and expert analysis, you’ll be equipped to make informed decisions and navigate the challenges of the Canadian oncology market.

Order your copy of the 2024 Oncology Market Access Insights Report today and gain a competitive edge in the rapidly evolving oncology landscape.

  • Canadian Reimbursement Forecasting Timelines Report
  • Canadian Reimbursement Forecasting Timelines Report 1

For further information, please complete the form below.

This report is only available to pharmaceutical companies to assist with their reimbursement forecasting and planning.

We're committed to your privacy. MORSE may use the information you provide to us to contact you about our relevant content and services. Your name, address and all other personal information will not be sold or given to any other organization or list distributor. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

Oncology Market Access Trends & Insights